Co-Authors
This is a "connection" page, showing publications co-authored by Diana Giannarelli and Melissa Bersanelli.
Connection Strength
0.685
-
The right immune-modulation at the right time: thymosin a1 for prevention of severe COVID-19 in cancer patients. Future Oncol. 2021 Mar; 17(9):1097-1104.
Score: 0.232
-
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. Ther Adv Med Oncol. 2020; 12:1758835920968463.
Score: 0.228
-
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy. Immunotherapy. 2020 10; 12(15):1139-1148.
Score: 0.226